相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma
Lei Zhong et al.
INVESTIGATIONAL NEW DRUGS (2019)
Activation of Pyroptotic Cell Death Pathways in Cancer: Alternative Therapeutic approach
Kanipandian Nagarajan et al.
TRANSLATIONAL ONCOLOGY (2019)
Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review
Aisha A. Hussein et al.
EUROPEAN JOURNAL OF CANCER (2017)
Death by HDAC Inhibition in Synovial Sarcoma Cells
Aimee N. Laporte et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells
Fengshan Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma
U. Heinicke et al.
ONCOGENE (2016)
Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation
Lianmin Bao et al.
CELL BIOLOGY AND TOXICOLOGY (2016)
Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth
Sung Eun Kim et al.
NATURE NANOTECHNOLOGY (2016)
The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase
Tzu-Chin Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Epigenetic changes and functional study of HOXA11 in human gastric cancer
Yingying Cui et al.
EPIGENOMICS (2015)
Epigenetic changes in BRCA1-mutated familial breast cancer
Bradley Downs et al.
CANCER GENETICS (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage
Renato Heidor et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
X. Li et al.
CELL DEATH & DISEASE (2014)
Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
Nadarajah Vigneswaran et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2014)
Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model
Deepali Kurundkar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
The importance of stromal inflammation in squamous cell carcinoma of the tongue
Lotta Lundqvist et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
Histone deacetylases and cancer
Bruna Barneda-Zahonero et al.
MOLECULAR ONCOLOGY (2012)
Histone deacetylase-1 and-2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
Stamatios Theocharis et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2011)
Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (II)
Ibrahim O. Bello et al.
ORAL ONCOLOGY (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
Janine Arts et al.
CLINICAL CANCER RESEARCH (2009)
Clinical Studies of Histone Deacetylase Inhibitors
H. Miles Prince et al.
CLINICAL CANCER RESEARCH (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications
C. Scully et al.
ORAL DISEASES (2009)
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
Jennifer S. Carew et al.
CANCER LETTERS (2008)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
HDACs and HDAC inhibitors in colon cancer
John M. Mariadason
EPIGENETICS (2008)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Functions of Site-Specific Histone Acetylation and Deacetylation
Mona D. Shahbazian et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2007)
Molecular genetics of premalignant oral lesions
S. K. Mithani et al.
ORAL DISEASES (2007)
Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation
M. Firdos Ziauddin et al.
NEOPLASIA (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
H Brenner
LANCET (2002)
Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults
K Annertz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
AL Kung et al.
NATURE MEDICINE (2000)
Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells
YB Kim et al.
JOURNAL OF ANTIBIOTICS (2000)
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
PA Marks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
